뇌성 마비 치료 시장 : 시장 규모, 점유율, 성장 분석 - 약제 유형별, 질환 유형별, 유통 채널별, 지역별 - 산업 예측(2025-2032년)
Cerebral Palsy Treatment Market Size, Share, Growth Analysis, By Drug Type (Anticholinergics, Anticonvulsants), By Disease Type (Spastic Cerebral Palsy, Dyskinetic Cerebral Palsy), By Distribution Channel, By Region - Industry Forecast 2025-2032
상품코드:1623708
리서치사:SkyQuest
발행일:2024년 12월
페이지 정보:영문 157 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 뇌성 마비 치료 시장 규모는 2023년에 33억 2,000만 달러로 평가되었고, 2024년 34억 5,000만 달러에서 2032년에는 44억 5,000만 달러로 성장할 전망이며, 예측 기간 2025년부터 2032년까지 CAGR은 3.3%로 성장할 전망입니다.
세계의 뇌성 마비 치료 시장은 유병률의 상승과 건강 관리 전문가 및 일반 시민의 인지도 향상으로 큰 성장을 이루고 있습니다. 뇌성 마비는 운동 능력과 협조성에 울림을 미치는 신경질환이며, 이 환자에게는 효과적인 치료가 필요합니다. 의료 기술의 진보로 조기 발견 및 진단이 향상되어, 시의적절한 개입으로 이어지고 있습니다. 약물 요법, 수술, 재활 요법, 보조 기구 등 혁신적인 치료법의 연구 개발의 활발화도 시장 확대를 뒷받침하고 있습니다. 또한 정부의 지원책과 상환 정책이 치료에 대한 접근성을 높이고 있습니다. 그러나 약제의 부작용이나 비외과적 접근으로의 이행과 같은 과제는 선진지역에서의 기존 외과적 치료의 성장을 저해할 가능성이 있습니다.
목차
서문
조사의 목적
조사 범위
정의
조사 방법
정보 조달
2차 데이터 및 1차 데이터의 방법
시장 규모 예측
시장의 전제조건 및 제한
주요 요약
세계 시장 전망
공급과 수요 동향 분석
부문별 기회 분석
시장 역학 및 전망
시장 개요
시장 규모
시장 역학
성장 촉진요인 및 기회
성장 억제요인 및 과제
Porter's Five Forces 분석
주요 시장 인사이트
중요성공요인
경쟁도
주요 투자 기회
시장 생태계
시장의 매력 지수(2024년)
PESTEL 분석
거시경제지표
밸류체인 분석
가격 분석
규제 상황
사례 연구
기술의 진보
뇌성 마비 치료 시장 규모 : 약물 유형별
시장 개요
항콜린제
항경련제
항우울제
기타
뇌성 마비 치료 시장 규모 : 질병 유형별
시장 개요
경련 뇌성 마비
운동장애성뇌성마비
운동 실조성 뇌성 마비
혼합성 뇌성 마비
뇌성 마비 치료 시장 규모 : 유통 채널별
시장 개요
병원 약국
소매점과 약국
온라인 제공업체
뇌성 마비 치료 시장 규모
북미
미국
캐나다
유럽
독일
스페인
프랑스
영국
이탈리아
기타 유럽
아시아태평양
중국
인도
일본
한국
기타 아시아태평양
라틴아메리카
브라질
기타 라틴아메리카
중동 및 아프리카
GCC 국가
남아프리카
기타 중동 및 아프리카
경쟁 정보
상위 5개사 비교
주요 기업의 시장 포지셔닝(2024년)
주요 시장 기업이 채용한 전략
시장의 최근 동향
기업의 시장 점유율 분석(2024년)
주요 기업의 기업 프로파일
기업 개요
제품 포트폴리오 분석
부문별 점유율 분석
수익의 전년 대비 비교(2022-2024년)
주요 기업 프로파일
Ipsen Biopharmaceuticals Inc.(France)
Merz GmbH & Co. KGaA(Germany)
Teva Pharmaceutical Industries Ltd.(Israel)
Supernus Pharmaceuticals, Inc.(USA)
AbbVie Inc.(USA)
Pfizer Inc.(USA)
Novartis AG(Switzerland)
Bayer AG(Germany)
Johnson & Johnson(USA)
GlaxoSmithKline plc(UK)
Medtronic plc(Ireland)
Allergan plc(Ireland)
Boston Scientific Corporation(USA)
Lannett Company, Inc.(USA)
Revance Therapeutics, Inc.(USA)
Hope Biosciences(USA)
MGC Pharmaceuticals(Australia)
Proveca Ltd(UK)
Baylx Inc.(USA)
Rohto Pharmaceutical Co., Ltd.(Japan)
결론 및 권장사항
AJY
영문 목차
영문목차
Global Cerebral Palsy Treatment Market size was valued at USD 3.32 billion in 2023 and is poised to grow from USD 3.45 billion in 2024 to USD 4.45 billion by 2032, growing at a CAGR of 3.3% during the forecast period (2025-2032).
The global cerebral palsy treatment market is experiencing significant growth, driven by the rising prevalence of the condition and enhanced awareness among healthcare professionals and the public. Cerebral palsy, a neurological disorder impacting motor skills and coordination, necessitates effective therapies for affected individuals. Advancements in medical technologies have improved early detection and diagnosis, leading to timely interventions. Increased research and development into innovative treatment options, including medications, surgeries, rehabilitation therapies, and assistive devices, are also fostering market expansion. Additionally, supportive government initiatives and reimbursement policies are enhancing access to treatments. However, challenges like drug side effects and a shift towards non-surgical approaches may inhibit the growth of traditional surgical treatments in developed regions.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Cerebral Palsy Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Cerebral Palsy Treatment Market Segmental Analysis
Global Cerebral Palsy Treatment Market is segmented by drug type, disease type, distribution channel and region. Based on drug type, the market is segmented into anticholinergics, anticonvulsants, antidepressants and other. Based on disease type, the market is segmented into spastic cerebral palsy, dyskinetic cerebral palsy, ataxic cerebral palsy and mixed cerebral palsy. Based on distribution channel, the market is segmented into hospital pharmacies, retail stores and pharmacy and online providers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Cerebral Palsy Treatment Market
The global cerebral palsy treatment market is primarily driven by several key factors, including a rise in the prevalence of cerebral palsy cases, which has intensified research efforts and healthcare innovations. Advances in healthcare technology have improved treatment options and facilitated access to newer medications for patients. Furthermore, enhanced research and development capabilities within the medical field are contributing to more effective therapies. Additionally, government initiatives aimed at increasing awareness and understanding of cerebral palsy, coupled with a growing reliance on pharmaceutical solutions, are further propelling the growth of this market, ensuring better care for affected individuals.
Restraints in the Global Cerebral Palsy Treatment Market
The global cerebral palsy treatment market is likely to encounter significant restraints primarily due to the high costs associated with medications. These expenses can deter patients and healthcare providers from pursuing effective treatment options. Furthermore, the adverse side effects linked to these therapies, such as fatigue, depression, headaches, lethargy, confusion, and dizziness, contribute to the challenges faced in this market. Additionally, inadequate awareness and understanding of cerebral palsy in underdeveloped and low-income regions further complicate treatment accessibility, thereby impeding the overall growth and expansion of the cerebral palsy treatment market on a global scale.
Market Trends of the Global Cerebral Palsy Treatment Market
The global cerebral palsy treatment market is experiencing notable trends driven by increasing awareness and technological advancements. A surge in demand for innovative therapeutics such as stem cell therapy and robotic rehabilitation is reshaping treatment landscapes. Emphasis on early intervention and multidisciplinary care approaches is crucial for optimizing patient outcomes. Additionally, heightened research and development efforts aim to introduce novel medications and therapies. The shift toward patient-centric care fosters the establishment of support programs and online communities, empowering individuals and families. As healthcare costs rise, emphasis on cost-effective solutions and favorable reimbursement policies is becoming essential, ultimately enhancing the quality of life for those affected by cerebral palsy.
Table of Contents
Introduction
Objectives of the Study
Scope of the Report
Definitions
Research Methodology
Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations
Executive Summary
Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis
Market Dynamics & Outlook
Market Overview
Market Size
Market Dynamics
Drivers & Opportunities
Restraints & Challenges
Porters Analysis
Competitive rivalry
Threat of substitute
Bargaining power of buyers
Threat of new entrants
Bargaining power of suppliers
Key Market Insights
Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2024
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Regulatory Landscape
Case Studies
Technological Advancement
Global Cerebral Palsy Treatment Market Size by Drug Type & CAGR (2025-2032)
Market Overview
Anticholinergics
Anticonvulsants
Antidepressants
Other
Global Cerebral Palsy Treatment Market Size by Disease Type & CAGR (2025-2032)
Market Overview
Spastic Cerebral Palsy
Dyskinetic Cerebral Palsy
Ataxic Cerebral Palsy
Mixed Cerebral Palsy
Global Cerebral Palsy Treatment Market Size by Distribution Channel & CAGR (2025-2032)
Market Overview
Hospital Pharmacies
Retail Stores and Pharmacy
Online Providers
Global Cerebral Palsy Treatment Market Size & CAGR (2025-2032)
North America (Drug Type, Disease Type, Distribution Channel)
US
Canada
Europe (Drug Type, Disease Type, Distribution Channel)
Germany
Spain
France
UK
Italy
Rest of Europe
Asia Pacific (Drug Type, Disease Type, Distribution Channel)
China
India
Japan
South Korea
Rest of Asia-Pacific
Latin America (Drug Type, Disease Type, Distribution Channel)
Brazil
Rest of Latin America
Middle East & Africa (Drug Type, Disease Type, Distribution Channel)